Haitao Yang, Scientific Director

发布者:冯明静发布时间:2020-05-20浏览次数:28

  Haitao Yang, Ph.D.

Scientific Director of Discovery Technology Platform

Executive Director of SIAIS

Principal Investigator

Shanghai Institute for Advanced Immunochemical Studies (SIAIS)

Associate Professor

School of Life Science and Technology (SLST)

Email: yanght@@shanghaitech.edu.cn


Education and Working Experience

1997-2001, Sichuan University, B.S.

2001-2006, Tsinghua University, Ph. D.

2006-2011, Yale University, Postdoctoral Fellow

2011-2013, Yale University, Associate Research Scientist

2013-2017, Tianjin University, Full Professor & Vice Dean of School of Life Sciences

2018-present, ShanghaiTech University, Shanghai Institute for Advanced Immunochemical Studies (SIAIS), Research Professor/Deputy Director/Executive Director

2018-present, ShanghaiTech University, School of Life Science and Technology, Associate Professor

Research Interests

Viruses are significant pathogens involved in human diseases throughout human history. Many of these virus-related human diseases have zoonotic origins, such as AIDS, bird flu, and severe acute respiratory syndrome (SARS). We focus on the essential stages of the viral life cycle: cellular entry, replication and transcription of the viral genome, and virion assembly and release to identify the pivotal targets for drug development.

To study the underlying mechanisms of interplay between viruses and their hosts will also help reveal new drug targets. Innate host immunity is the first line of defense against pathogen infection, playing a critical role in host resistance to pathogenic microorganisms. Interestingly, the viruses have evolved a variety of strategies to antagonize host restriction and escape the innate immune response. The interaction between host antiviral proteins and viral antagonizing proteins constitutes a dynamic and sophisticated network. Thus, strategies that boost the roles of host restriction while diminishing viral antagonism may lead to new therapies against viral infection.

Selected Publications

  1. Lu Lu*; Su Shan; Yang Haitao#; Jiang Shibo#.Antivirals with common targets against highly pathogenic viruses. CELL. 18 Mar 2021. 184(6):1604-1620.

  2. Cui,Wen*; Braun,Elisabeth*; Wang,Wei*; Tang,Jinhong*; Zheng,Yanyan*; Slater,Benjamin; Li,Na; Chen,Cheng; Liu,Qingxiang; Wang,Bin; Li,Xiu; Duan,Yinkai; Xiao,Yunjie; Ti,Rujiao; Hotter,Dominik; Ji,Xiaoyun; Zhang,Lei; Cui,Jun; Xiong,Yong; Sauter,Daniel#; Wang,Zefang#; Kirchhoff,Frank#; Yang,Haitao#.Structural basis for GTP-induced dimerization and antiviral functioin of guanylate-binding proteins.PNAS. 13 Apr 2021. 118(15).             

  3. Jin, Zhenming*; Du, Xiaoyu*; Xu, Yechun*; Deng, Yongqiang*; Liu, Meiqin*; Zhao, Yao; Zhang, Bing; Li, Xiaofeng; Zhang, Leike; Peng, Chao; Duan, Yinkai; Yu, Jing; Wang, Lin; Yang, Kailin; Liu, Fengjiang; Jiang, Rendi; Yang, Xinglou; You, Tian; Liu, Xiaoce; Yang, Xiuna; Bai, Fang; Liu, Hong; Liu, Xiang; Guddat, Luke W.; Xu, Wenqing; Xiao, Gengfu; Qin, Chengfeng; Shi, Zhengli; Jiang, Hualiang#; Rao, Zihe#; Yang, Haitao#.Structure of M-pro from SARS-CoV-2 and discovery of its inhibitors.NATURE. 09 Apr 2020.

  4. Dai, Wenhao*; Zhang, Bing*; Jiang, Xia-Ming*; Su, Haixia*; Li, Jian; Zhao, Yao; Xie, Xiong; Jin, Zhenming; Peng, Jingjing; Liu, Fengjiang; Li, Chunpu; Li, You; Bai, Fang; Wang, Haofeng; Cheng, Xi; Cen, Xiaobo; Hu, Shulei; Yang, Xiuna; Wang, Jiang; Liu, Xiang; Xiao, Gengfu; Jiang, Hualiang; Rao, Zihe; Zhang, Lei-Ke#; Xu, Yechun#; Yang, Haitao#; Liu, Hong#.Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.SCIENCE. 19 Jun 2020. 368(6497):1331-1335.

  5. Wang, Quan#*; Wu, Jiqin*; Wang, Haofeng*; Gao, Yan*; Liu, Qiaojie*; Mu, An; Ji, Wenxin; Yan, Liming; Zhu, Yan; Zhu, Chen; Fang, Xiang; Yang, Xiaobao; Huang, Yucen; Gao, Hailong; Liu, Fengjiang; Ge, Ji; Sun, Qianqian; Yang, Xiuna; Xu, Wenqing; Liu, Zhijie; Yang, Haitao; Lou, Zhiyong; Jiang, Biao; Guddat, Luke W.; Gong, Peng#; Rao, Zihe#.Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.CELL. 23 Jul 2020. 182(2):417.

  6. Jin, Zhenming*; Zhao, Yao*; Sun, Yuan*; Zhang, Bing; Wang, Haofeng; Wu, Yan; Zhu, Yan; Zhu, Chen; Hu, Tianyu; Du, Xiaoyu; Duan, Yinkai; Yu, Jing; Yang, Xiaobao; Yang, Xiuna; Yang, Kailin; Liu, Xiang; Guddat, Luke W.; Xiao, Gengfu; Zhang, Leike#; Yang, Haitao#; Rao, Zihe.Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.NATURE STRUCTURAL & MOLECULAR BIOLOGY. 07 May 2020.

  7. Gao, Yan*; Yan, Liming*; Huang, Yucen*; Liu, Fengjiang*; Zhao, Yao; Cao, Lin; Wang, Tao; Sun, Qianqian; Ming, Zhenhua; Zhang, Lianqi; Ge, Ji; Zheng, Litao; Zhang, Ying; Wang, Haofeng; Zhu, Yan; Zhu, Chen; Hu, Tianyu; Hua, Tian; Zhang, Bing; Yang, Xiuna; Li, Jun; Yang, Haitao; Liu, Zhijie; Xu, Wenqing; Guddat, Luke W.; Wang, Quan#; Lou, Zhiyong#; Rao, Zihe#.Structure of the RNA-dependent RNA polymerase from COVID-19 virus.SCIENCE. 15 May 2020. 368(6492):779-+.

  8. Zhang, Lu*; Zhao, Yao*; Gao, Yan; Wu, Lijie; Gao, Ruogu; Zhang, Qi; Wang, Yinan; Wu, Chengyao; Wu, Fangyu; Gurcha, Sudagar S.; Veerapen, Natacha; Batt, Sarah M.; Zhao, Wei; Qin, Ling; Yang, Xiuna; Wang, Manfu; Zhu, Yan; Zhang, Bing; Bi, Lijun; Zhang, Xian'en; Yang, Haitao; Guddat, Luke W.; Xu, Wenqing; Wang, Quan#; Li, Jun#; Besra, Gurdyal S.#; Rao, Zihe#.Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol.SCIENCE. 12 Jun 2020. 368(6496):1211.

  9. Liu, Fengjiang*; Liang, Jingxi*; Zhang, Bing#*; Gao, Yan*; Yang, Xiuna; Hu, Tianyu; Yang, Haitao; Xu, Wenqing; Guddat, Luke W.; Rao, Zihe#.Structural basis of trehalose recycling by the ABC transporter LpqY-SugABC.SCIENCE ADVANCES. Oct 2020. 6(44).

  10. Zhang, Bing*; Li, Jun#; Yang, Xiaolin; Wu, Lijie; Zhang, Jia; Yang, Yang; Zhao, Yao; Zhang, Lu; Yang, Xiuna; Yang, Xiaobao; Cheng, Xi; Liu, Zhijie; Jiang, Biao; Jiang, Hualiang; Guddat, Luke W.; Yang, Haitao#; Rao, Zihe#.Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target.CELL. 24 Jan 2019. 176(3):636-+.